BIZTRAC BETA
Manufacture of pharmaceutical preparations

APPSENS AS

Org. no. 918707719 Limited company (AS) Lillesand Incorporated 2017 Active
Ownership graph ↗
Revenue 2025 NOK 10.8m
Operating profit NOK −10.4m
Equity NOK 7.5m
Incorporated 2017
Employees 8
Share capital NOK 128,000

Signals

2 flags
  • Driftsunderskudd 2025 Siste driftsresultat er negativt (−10,4 mill kr).
  • Nylig endring 2026-04-23 Aksjekapital registrert 2026-04-23.

APPSENS AS is registered as a limited company in Lillesand, Agder with organisation number 918707719. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2017 and has 8 registered employees. Registered share capital is NOK 128,000, divided into 127952 shares. The company's stated purpose is: “Utvikling og investeringer i produkter og tjenester.”. The most recent filed accounts, for the 2025 financial year, show NOK 10.8m in revenue and NOK −10.4m in operating profit.

Key figures · 2025

Revenue
NOK 10.8m
Operating profit
NOK −10.4m
Equity
NOK 7.5m
Est. value
NOK 9.8m

Financial health · 2025

Liquidity
3.44
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
49.4%
Very good
Equity as a share of total capital

Who owns APPSENS AS?

UTHALDEN AS
APPSENS AS
NOK 10.8m rev. · NOK −10.4m profit

APPSENS AS has 20+ registered shareholders:

All shareholders and roles →

Frequently asked questions about APPSENS AS

Who owns APPSENS AS?

UTHALDEN AS is the largest registered owner, with 20.1%.

What is the revenue of APPSENS AS?

APPSENS AS had revenue of NOK 10.8m in 2025.

Who is the general manager of APPSENS AS?

Tord Ytterdahl is registered as general manager of APPSENS AS.

Where is APPSENS AS based?

APPSENS AS has its business address in Lillesand.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.